Works by Kukreti, Vishal

Results: 68
    1
    2
    3
    4

    Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.

    Published in:
    European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
    By:
    • Zangari, Maurizio;
    • Aujay, Monette;
    • Fenghuang Zhan;
    • Hetherington, Kristina L.;
    • Berno, Tamara;
    • Vij, Ravi;
    • Jagannath, Sundar;
    • Siegel, David;
    • Stewart, A. Keith;
    • Wang, Luhua;
    • Orlowski, Robert Z.;
    • Belch, Andrew;
    • Jakubowiak, Andrzej;
    • Somlo, George;
    • Trudel, Suzanne;
    • Bahlis, Nizar;
    • Lonial, Sagar;
    • Singhal, Seema;
    • Kukreti, Vishal;
    • Tricot, Guido
    Publication type:
    Article
    5
    6

    Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 12, p. 1538, doi. 10.1002/ajh.26726
    By:
    • Lackraj, Tracy;
    • Ben Barouch, Sharon;
    • Medeiros, Jessie J. F.;
    • Pedersen, Stephanie;
    • Danesh, Arnavaz;
    • Bakhtiari, Mehran;
    • Hong, Michael;
    • Tong, Kit;
    • Joynt, Jesse;
    • Arruda, Andrea;
    • Minden, Mark D.;
    • Kuruvilla, John;
    • Bhella, Sita;
    • Kukreti, Vishal;
    • Crump, Michael;
    • Prica, Anca;
    • Chen, Christine;
    • Deng, Yangqing;
    • Xu, Wei;
    • Pugh, Trevor J.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    An open-label, pharmacokinetic study of lenalidomide and dexamethasone therapy in previously untreated multiple myeloma (MM) patients with various degrees of renal impairment – validation of official dosing guidelines.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 8, p. 1860, doi. 10.1080/10428194.2020.1747064
    By:
    • Chen, Christine I.;
    • Cao, Yanshuo;
    • Trudel, Suzanne;
    • Reece, Donna E.;
    • Kukreti, Vishal;
    • Tiedemann, Rodger;
    • Prica, Anca;
    • Paul, Harminder;
    • Le, Lisa W.;
    • Levina, Olga;
    • Kakar, Sumeet;
    • Lau, Anthea;
    • Chen, Hongzhuan;
    • Chen, Eric
    Publication type:
    Article
    18
    19
    20

    A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 6, p. 1463, doi. 10.3109/10428194.2015.1091927
    By:
    • Hay, Annette E.;
    • Murugesan, Alli;
    • DiPasquale, Ashley M.;
    • Kouroukis, Tom;
    • Sandhu, Irwindeep;
    • Kukreti, Vishal;
    • Bahlis, Nizar J.;
    • Lategan, Johan;
    • Reece, Donna E.;
    • Lyons, John F.;
    • Sederias, Joana;
    • Xu, Hao;
    • Powers, Jean;
    • Seymour, Lesley K.;
    • Reiman, Tony
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 4, p. 483, doi. 10.1111/bjh.12414
    By:
    • Chen, Christine I.;
    • Masih‐Khan, Esther;
    • Jiang, Haiyan;
    • Rabea, Ahmed;
    • Cserti‐Gazdewich, Christine;
    • Jimenez‐Zepeda, Victor H.;
    • Chu, Chia‐Min;
    • Kukreti, Vishal;
    • Trudel, Suzanne;
    • Tiedemann, Rodger;
    • Tsang, Richard;
    • Reece, Donna E.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐DICEP) versus R‐GDP

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 881, doi. 10.1111/bjh.19555
    By:
    • Stewart, Douglas A.;
    • Kuruvilla, John;
    • Lee, David;
    • Dudebout, Jill J.;
    • Chua, Neil;
    • Larouche, Jean‐François;
    • Baetz, Tara;
    • Shafey, Mona;
    • Abdel‐Samad, Nizar;
    • Robinson, Sue;
    • Fleury, Isabelle;
    • Fraser, Graeme;
    • Skrabek, Pamela;
    • Kukreti, Vishal;
    • Kelly, Jesse;
    • Hay, Annette E.;
    • Shepherd, Lois E.;
    • Chen, Bingshu E.;
    • Crump, Michael
    Publication type:
    Article
    43

    Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma.

    Published in:
    British Journal of Haematology, 2020, v. 190, n. 6, p. 864, doi. 10.1111/bjh.16777
    By:
    • Calvente, Lourdes;
    • Tremblay‐LeMay, Rosemarie;
    • Xu, Wei;
    • Chan, Fong Chun;
    • Hong, Michael;
    • Zhang, Tong;
    • Yhim, Ho‐Young;
    • Kuruvilla, John;
    • Crump, Michael;
    • Kukreti, Vishal;
    • Prica, Anca;
    • Regier, Dean;
    • Marra, Marco A.;
    • Karsan, Aly;
    • Steidl, Christian;
    • Scott, David W.;
    • Sabatini, Peter;
    • Kridel, Robert
    Publication type:
    Article
    44
    45
    46
    47
    48

    Ambulatory Toxicity Management (AToM) Pilot: results of a pilot study of a pro-active, telephone-based intervention to improve toxicity management during chemotherapy for breast cancer.

    Published in:
    Pilot & Feasibility Studies, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40814-019-0404-y
    By:
    • Krzyzanowska, Monika K.;
    • MacKay, Cassandra;
    • Han, Heekyung;
    • Eberg, Maria;
    • Gandhi, Sonal;
    • Laferriere, Nicole B.;
    • Powis, Melanie;
    • Howell, Doris;
    • Atzema, Clare L.;
    • Chan, Kelvin K. W.;
    • Kukreti, Vishal;
    • Mitchell, Sandra;
    • Nayer, Marla;
    • Pasetka, Mark;
    • Knittel-Keren, Dafna;
    • Redwood, Erin
    Publication type:
    Article
    49
    50